Contact
Please use this form to send email to PR contact of this press release:
Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) Extended Trial Shows Patients Can Avoid Total Knee Replacement
TO:
Emerging Growth Staff
EmergingGrowth.com
305-330-1985